Other investigators reported that plasma levels of IL-33 were significantly higher in patients with acute coronary syndrome compared with stable angina or control subjects [19], and that plasma IL-33 levels predicted carotid plaque progression in patients with early rheumatoid arthritis [20], raising the possibility that IL-33 is involved in the pathophysiology of atherosclerosis. This evidence concerns the gene IL33 and acute coronary syndrome.